Literature DB >> 11004328

The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy.

G Vlastos1, B D Fornage, N Q Mirza, D Bedi, J T Lenert, D J Winchester, S M Tolley, F C Ames, M I Ross, B W Feig, K K Hunt, A U Buzdar, S E Singletary.   

Abstract

BACKGROUND: The goal of this study was to examine the role of ultrasonography in detecting axillary lymph node metastases in stage II breast cancer patients after induction chemotherapy (IC).
METHODS: Of 172 consecutive patients with T1-3, N0-1, M0 breast cancer registered in a prospective IC trial, a subset of 130 evaluable patients were chosen, with (1) both physical and ultrasonographic examinations of the axilla before and after IC; (2) exactly four cycles of IC; (3) no presurgical radiation therapy; and (4) an axillary lymph node dissection.
RESULTS: Before IC, 32 patients (25%) were negative for axillary involvement by both physical and ultrasonographic examinations. After IC, this number increased to 64 (49%). Of these, 31 (48%) were positive by pathology examination. In most cases, however, the residual tumor was minimal.
CONCLUSIONS: Stage II breast cancer patients who were or became node negative by both ultrasonographic and physical examinations after IC had a 48% incidence of nodal metastases. Because the residual tumor was minimal, irradiation may be sufficient for adequate local control of the axilla.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11004328     DOI: 10.1016/s0002-9610(00)00382-2

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  8 in total

1.  Long-term follow-up of breast-conserving therapy in patients with inflammatory breast cancer treated with neoadjuvant chemotherapy.

Authors:  Valentina Bonev; Maristella Evangelista; Jeon-Hor Chen; Min-Ying Su; Karen Lane; Rita Mehta; John Butler; David Hsiang
Journal:  Am Surg       Date:  2014-10       Impact factor: 0.688

Review 2.  Accuracy of axillary ultrasound in the diagnosis of nodal metastasis in invasive breast cancer: a review.

Authors:  Jonathan Cools-Lartigue; Sarkis Meterissian
Journal:  World J Surg       Date:  2012-01       Impact factor: 3.352

3.  Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer.

Authors:  Laura S Dominici; Viviana M Negron Gonzalez; Aman U Buzdar; Anthony Lucci; Elizabeth A Mittendorf; Huong T Le-Petross; Gildy V Babiera; Funda Meric-Bernstam; Kelly K Hunt; Henry M Kuerer
Journal:  Cancer       Date:  2010-06-15       Impact factor: 6.860

4.  International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment.

Authors:  S Dawood; S D Merajver; P Viens; P B Vermeulen; S M Swain; T A Buchholz; L Y Dirix; P H Levine; A Lucci; S Krishnamurthy; F M Robertson; W A Woodward; W T Yang; N T Ueno; M Cristofanilli
Journal:  Ann Oncol       Date:  2010-07-05       Impact factor: 32.976

5.  The value of ultrasound in detecting extra-axillary regional node involvement in patients with advanced breast cancer.

Authors:  Puneeth Iyengar; Eric A Strom; Yu-Jing Zhang; Gary J Whitman; Benjamin D Smith; Wendy A Woodward; Tse-Kuan Yu; Thomas A Buchholz
Journal:  Oncologist       Date:  2012-09-14

6.  Local and regional staging of invasive breast cancer with sonography: 25 years of practice at MD Anderson Cancer Center.

Authors:  Bruno D Fornage
Journal:  Oncologist       Date:  2013-12-05

7.  Number of Axillary Lymph Node Metastases Determined by Preoperative Ultrasound is Related to Prognosis in Patients with Breast Cancer.

Authors:  Yuko Kijima; Heiji Yoshinaka; Munetsugu Hirata; Tadao Mizoguchi; Sumiya Ishigami; Akihiro Nakajo; Hideo Arima; Shinichi Ueno; Shoji Natsugoe
Journal:  Cancers (Basel)       Date:  2010-02-04       Impact factor: 6.639

Review 8.  Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials.

Authors:  Raquel F D van la Parra; Henry M Kuerer
Journal:  Breast Cancer Res       Date:  2016-03-08       Impact factor: 6.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.